An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors

American Heart Journal
A A Adgey

Abstract

The era of platelet glycoprotein (GP) IIb/IIIa receptor inhibition in cardiology was inaugurated in 1994 with the publication of the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial results. EPIC demonstrated that the GP IIb/IIIa blocker abciximab, administered as a bolus and 12-hour infusion, afforded protection against ischemic complications in high-risk patients undergoing angioplasty and atherectomy, including those with unstable angina or evolving myocardial infarction (MI). A significant reduction in the incidence of death, acute MI, or revascularization was apparent at 30 days and also sustained at 6-month and 3-year follow-up. The subsequent Evaluation in PTCA to Improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade (EPILOG) study extended these findings to the full spectrum of coronary intervention patients, confirming that abciximab provided similar benefits in low-risk patients as well. The EPILOG trial also proved that any excess bleeding risk associated with potent antiplatelet therapy could be brought down to placebo levels through the use of a low-dose, weight-adjusted heparin regimen, early vascular sheath removal, and elimination of routine postprocedural heparinization. The p...Continue Reading

References

Jun 12, 1997·The New England Journal of Medicine·UNKNOWN EPILOG Investigators
Apr 16, 1998·American Heart Journal·A K GoklaneyW B Hillegass

❮ Previous
Next ❯

Citations

Apr 28, 2000·International Journal of Clinical & Laboratory Research·M CapanniG F Gensini
Jun 18, 2002·Journal of Interventional Cardiology·David E Kandzari, Kenneth W Mahaffey
Sep 24, 1999·Clinical Cardiology·J T Willerson, P Zoldhelyi
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·W WangB Wang
Mar 16, 2000·British Journal of Clinical Pharmacology·B WittkeS J Machin
Jun 26, 2001·British Journal of Clinical Pharmacology·J GraffS Harder
Sep 30, 2000·Health Policy·S P McKenna, D Whalley
Feb 28, 2009·Journal of Interventional Cardiology·G ViswanathanA G Zaman
Jun 29, 1999·Cardiology Clinics·C TungM Gheorghiade
Aug 31, 2000·The Annals of Thoracic Surgery·J H Lemmer
Jul 30, 1999·American Heart Journal·J J Ferguson, K Taqi
Jul 13, 1999·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·H ArjomandD A Mascarenhas
Aug 31, 1999·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·M J SchalijA V Bruschke
Jan 31, 2008·Platelets·Jane F ArthurMichael C Berndt
Jul 18, 2001·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·M J LageJ Scherer
Jan 19, 2002·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·M S BarakateM K Morgan
Dec 8, 1998·Circulation·M MadanJ E Tcheng
Apr 16, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Marcus E McKenzieVictor L Serebruany
Aug 24, 2017·Cancers·Sabine Raab-WestphalSimon L Goodman
Mar 14, 2001·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·M J LageJ Scherer
Feb 10, 2021·Platelets·Siobhan Branfield, A Valance Washington

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.